503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-7.07%
Negative net income growth while ORCL stands at 73.54%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
-5.71%
Negative yoy D&A while ORCL is 22.31%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-55.93%
Negative yoy working capital usage while ORCL is 1.96%. Joel Greenblatt would see more free cash if revenue remains unaffected, giving a short-term advantage.
No Data
No Data available this quarter, please select a different quarter.
-105.88%
Negative yoy inventory while ORCL is 0.00%. Joel Greenblatt would see a near-term cash advantage if top-line doesn't suffer.
No Data
No Data available this quarter, please select a different quarter.
-44.06%
Negative yoy usage while ORCL is 1.96%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
No Data
No Data available this quarter, please select a different quarter.
-20.37%
Negative yoy CFO while ORCL is 66.36%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.
-118.63%
Both yoy lines negative, with ORCL at -14.62%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
No Data
No Data available this quarter, please select a different quarter.
239.64%
Purchases growth of 239.64% while ORCL is zero at 0.00%. Bruce Berkowitz sees a mild difference in portfolio building that might matter for returns.
No Data
No Data available this quarter, please select a different quarter.
-13800.00%
We reduce yoy other investing while ORCL is 92.75%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
124.94%
Investing outflow well above ORCL's 19.26%. Michael Burry sees possible short-term FCF risk unless these invests pay off quickly vs. competitor’s approach.
No Data
No Data available this quarter, please select a different quarter.
-130.49%
Negative yoy issuance while ORCL is 433.96%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
114.42%
Buyback growth of 114.42% while ORCL is zero at 0.00%. Bruce Berkowitz sees a modest per-share advantage that might accumulate if the stock is below intrinsic value.